Could Management of Blood Pressure Prevent Dementia in the elderly?
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Hypertension is one of the most relevant risk factors in vascular aging, stroke and vascular dementia (VD). In the elderly, the prevalence of mixed dementia, which consists of Alzheimer’s disease (AD) and VD, is increased. Moreover, disorders of blood vessels are reported to be involved in the onset and progression of AD. Thus, hypertension generally plays an important role in dementia overall. Main Text: Mid-life hypertension is reported to be related to the incidence of dementia, but it is reported that antihypertensive treatment in aged people cannot prevent the onset and progression of dementia. The reninangiotensin system (RAS) is deeply involved in not only hypertension but also lifestyle-related diseases, and may contribute to the pathological mechanism in dementia; thus, RAS regulation is expected to prevent dementia. Small vessel structural changes in lifestyle-related diseases may play a role in dementia in the elderly. Conclusion: Here, we discuss the role of blood pressure elevation in dementia and the therapeutic possibility of antihypertensive treatment against dementia.
Abstract
Background: Hypertension is one of the most relevant risk factors in vascular aging, stroke and vascular dementia (VD). In the elderly, the prevalence of mixed dementia, which consists of Alzheimer’s disease (AD) and VD, is increased. Moreover, disorders of blood vessels are reported to be involved in the onset and progression of AD. Thus, hypertension generally plays an important role in dementia overall. Main Text: Mid-life hypertension is reported to be related to the incidence of dementia, but it is reported that antihypertensive treatment in aged people cannot prevent the onset and progression of dementia. The reninangiotensin system (RAS) is deeply involved in not only hypertension but also lifestyle-related diseases, and may contribute to the pathological mechanism in dementia; thus, RAS regulation is expected to prevent dementia. Small vessel structural changes in lifestyle-related diseases may play a role in dementia in the elderly. Conclusion: Here, we discuss the role of blood pressure elevation in dementia and the therapeutic possibility of antihypertensive treatment against dementia.
참고문헌 (27)
- Kontis V, "Future life expectancy in 35 industrialised countries : projections with a bayesian model ensemble", Lancet, 389, pp.1323~1335 (2017)
- International WHOaAsD, "Dementia: a public health priority", ~ (2012)
- Mangialasche F, "Alzheimer's disease : clinical trials and drug development", Lancet Neurol, 9, pp.702~716 (2010)
- Livingston G, "Dementia prevention, intervention, and care", Lancet, 390, pp.2673~2734 (2017)
- "My life check | life's simple 7"[URL]
- Samieri C, "Association of cardiovascular health level in older age with cognitive decline and incident dementia", JAMA, 320, pp.657~664 (2018)
- Gottesman RF, "Midlife hypertension and 20-year cognitive change : the atherosclerosis risk in communities neurocognitive study", JAMA Neurol, 71, pp.1218~1227 (2014)
- Launer LJ, "Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia : perspective from the Honolulu heart program", Honolulu Asia aging study, 2010, pp.55, 1352~1359
- Abell JG, "Singh-Manoux a. association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension", Eur Heart J, 39, pp.3119~3125 (2018)
- Faraco G, "Hypertension : a harbinger of stroke and dementia", Hypertension, 62, pp.810~817 (2013)
- Qiu C, "A major role for cardiovascular burden in age-related cognitive decline", Nat Rev Cardiol, 12, pp.267~277 (2015)
- Peters R, "Incident dementia and blood pressure lowering in the hypertension in the very elderly trial cognitive function assessment(HYVET-COG) : a doubleblind, placebo controlled trial", Lancet Neurol, 7, pp.683~689 (2008)
- Peters R, "Orthostatic hypotension and symptomatic subclinical orthostatic hypotension increase risk of cognitive impairment : an integrated evidence review and analysis of a large older adult hypertensive cohort", Eur Heart J, 39, pp.3135~3143 (2018)
- Gard PR, "The role of angiotensin II in cognition and behaviour", Eur J Pharmacol, 438, pp.1~14 (2002)
- Georgiev V, "Participation of angiotensin II in learning and memory. I. Interaction of angiotensin II with saralasin", Methods Find Exp Clin Pharmacol, 7, pp.415~418 (1985)
- Costall B, "The effects of ACE inhibitors captopril and SQ29, 852 in rodent tests of cognition", Pharmacol Biochem Behav, 33, pp.573~579 (1989)
- Earley B, "Effects of captopril on locomotor activity, passive avoidance behaviour and spatial memory tasks in the trimethyltintreated rat", Neuropsychobiology, 22, pp.49~56 (1989)
- Kulakowska A, "Losartan influences behavioural effects of angiotensin II in rats", Pharmacol Res, 34, pp.109~115 (1996)
- Fukamizu A, "Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes", J Biol Chem, 268, pp.11617~11621 (1993)
- Inaba S, "Continuous activation of renin-angiotensin system impairs cognitive function in renin", angiotensinogen transgenic mice, 2009, pp.53, 356~362
- Min LJ, "Peroxisome proliferator-activated receptor-gamma activation with angiotensin II type 1receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice", Hypertension, 59, pp.1079~1088 (2012)
- Ito U, "Temporary cerebral ischemia results in swollen astrocytic end-feet that compress microvessels and lead to delayed focal cortical infarction", J Cereb Blood Flow Metab, 31, pp.328~338 (2011)
- Faraco G, "Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension", J Clin Invest, 126, pp.4674~4689 (2016)
- Li NC, "Use of angiotensin receptor blockers and risk of dementia in a predominantly male population : prospective cohort analysis", BMJ, 340, pp.b5465~ (2010)
- Gorelick PB, "Defining optimal brain health in adults : a presidential advisory from the American Heart Association", American Stroke Association, 2017, pp.48, e284~e303
- Iadecola C, "Impact of hypertension on cognitive function : a scientific statement from the American Heart Association", Hypertension, 68, pp.e67~e94 (2016)
- Kjeldsen SE, "Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain : the SPRINT memory and cognition IN decreased hypertension(SPRINT MIND)study", Blood Press, 27, pp.247~248 (2018)